George Migausky
Director/Board Member at IMMUNOVANT, INC.
Net worth: 3 M $ as of 2024-04-29
Profile
George V.
Migausky is an Independent Director at REGENXBIO, Inc., Director at Immunovant Sciences Ltd., and Trustee at Massachusetts Eye & Ear Infirmary, Inc. He previously served as an Independent Director at Abeona Therapeutics, Inc., Director at Rocket Pharmaceuticals, Inc., Director at Health Sciences Acquisitions Corp., Director at Immunovant, Inc., Chief Financial Officer & Executive Vice President at Dyax Corp., Chief Financial Officer & Vice President at BioVeris Corp., Chief Financial Officer at Ocular Therapeutix, Inc., and Chief Financial Officer at Wellstat Management Co. LLC.
He also served as a Manager at Deloitte & Touche.
He holds an MBA from Babson College and an undergraduate degree from Boston College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMMUNOVANT INC
0.08% | 2024-04-01 | 121,063 ( 0.08% ) | 3 M $ | 2024-04-29 |
REGENXBIO, INC.
0.01% | 2024-03-31 | 3,010 ( 0.01% ) | 48 341 $ | 2024-04-29 |
George Migausky active positions
Companies | Position | Start |
---|---|---|
IMMUNOVANT, INC. | Director/Board Member | 2019-12-17 |
REGENXBIO INC. | Director/Board Member | 2021-09-02 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Director/Board Member | 2020-02-29 |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Director/Board Member | 2014-12-31 |
Former positions of George Migausky
Companies | Position | End |
---|---|---|
ABEONA THERAPEUTICS INC. | Director/Board Member | 2020-09-26 |
DIMENSION THERAPEUTICS INC | Director/Board Member | 2017-11-06 |
OCULAR THERAPEUTIX, INC. | Director of Finance/CFO | 2017-09-24 |
DYAX CORP. | Director of Finance/CFO | 2016-01-21 |
Wellstat Management Co. LLC
Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Director of Finance/CFO | 2007-12-31 |
Training of George Migausky
Babson College | Masters Business Admin |
Boston College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
OCULAR THERAPEUTIX, INC. | Health Technology |
REGENXBIO INC. | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
IMMUNOVANT, INC. | Health Technology |
Private companies | 11 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology BioVeris Corp. developed and manufactured diagnostic products. It operates as a global health care and biosecurity company that developing proprietary technologies in diagnostics and vaccinology. The firm specializes in electrochemiluminescence and immunochemistry. The company was founded in 2003 and is headquartered in Gaithersburg, MD. | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
Deloitte & Touche
Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Commercial Services |
Massachusetts Eye & Ear Infirmary, Inc.
Massachusetts Eye & Ear Infirmary, Inc. Medical/Nursing ServicesHealth Services Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA. | Health Services |
Wellstat Management Co. LLC
Wellstat Management Co. LLC Miscellaneous Commercial ServicesCommercial Services Wellstat Management Co. LLC provides management, legal, financial, human resources, information technology, business development, transactional, investment, licensing, and other services to the Wellstat group of companies. The company was founded by Samuel J. Wohlstadter in 2007 and is headquartered in Rockville, MD. | Commercial Services |
Hyperion Catalysis International, Inc.
Hyperion Catalysis International, Inc. Miscellaneous ManufacturingProducer Manufacturing Hyperion Catalysis International is a private company that specializes in the development and commercialization of carbon nanotubes. The company is based in Cambridge, MA. Hyperion Catalysis supplies Fibril nanotubes pre-mixed in a range of plastics for use in automotive and electronics applications. Founded in 1982, the company's flagship technology is a conductive, vapor grown, multi-walled carbon nanotube called Fibril™. | Producer Manufacturing |
Dimension Therapeutics, Inc.
Dimension Therapeutics, Inc. BiotechnologyHealth Technology Dimension Therapeutics, Inc. engages in the development of novel treatments for rare diseases. Its activities include discoveries and development of therapeutic products for people living with rare diseases associated wit the liver and caused by genetic mutations. The company was founded by Ben Auspitz in June 20, 2013 and is headquartered in Cambridge, MA. | Health Technology |
Health Sciences Acquisitions Corp.
Health Sciences Acquisitions Corp. Financial ConglomeratesFinance Health Sciences Acquisitions Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It pursues prospective targets that are focused on healthcare innovation domiciled in North America or Europe that are developing assets in the biopharma and medical technology sectors. The company was founded on December 06, 2018 and is headquartered in New York, NY. | Finance |
Immunovant, Inc. /Old/
Immunovant, Inc. /Old/ BiotechnologyHealth Technology Immunovant, Inc. is a biopharmaceutical company, which engages in the development of therapies for autoimmune diseases. It focuses on its product pipeline, IMVT-1401, which is a human recombinant anti-neonatal Fc receptor monoclonal antibody for the treatment of IgG mediated diseases. The company is headquartered in New York, NY. | Health Technology |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Health Technology |
- Stock Market
- Insiders
- George Migausky